Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009579 |
---|---|
Receipt number | R000011240 |
Scientific Title | Phase II study of personalized titration of axitinib using therapeutic drug monitoring (TDM) in sunitinib-refractory metastatic or advanced renal cell carcinoma |
Date of disclosure of the study information | 2012/12/19 |
Last modified on | 2018/09/27 16:45:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/12/19 05:38:39 | ||
2 | Update | 2013/07/02 12:46:55 | Recruitment status |
|
3 | Update | 2013/12/20 11:51:58 | Last name of lead principal investigator Last name of lead principal investigator |
|
4 | Update | 2015/06/19 19:49:40 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2015/10/14 21:01:12 | Recruitment status |
|
6 | Update | 2016/12/23 08:42:41 | Name of primary person or sponsor Organization |
|
7 | Update | 2017/07/15 07:42:12 | Publication of results |
|
8 | Update | 2018/09/27 16:45:09 | Recruitment status Publication of results |